As we all know the JP Morgan Healthcare conference is an invitation-only conference. For this reason, I have summarized various announcements for the purpose of this review. As we have witnessed in the past, exciting announcements happen here in San Francisco around or just before this annual conference, and some of the news spark what eventually will become the big trends throughout the year. One could say it is a window to what is just around the corner in 2019.
Several commercial tool providers and diagnostic companies used this venue to announce their strategies or to provide a status update:
- Qiagen announced that they will acquire N-of-One. The addition of N-of-One will enable QIAGEN to significantly expand its decision-support solutions while offering a broader range of software, content with access to the MarkerMine™ database, and service-based solutions.
- 10X Genomics raised $35 million in financing in an extension of its April Series D for single-cell sequencing which brings 10X’s total amount raised to $243 million.